Rua Bioscience (NZSE:RUA) Total Current Assets : NZ$2.87 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Rua Bioscience's total current assets for the quarter that ended in Dec. 2024 was NZ$2.87 Mil.

Rua Bioscience Total Current Assets Historical Data

The historical data trend for Rua Bioscience's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Total Current Assets Chart

Rua Bioscience Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Total Current Assets

18.39

11.39

5.60

2.82

Rua Bioscience Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Current Assets	Get a 7-Day Free Trial				7.77	5.60	4.84	2.82	2.87

Rua Bioscience Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Rua Bioscience's Total Current Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.895	+	0.277	+	0.278	+	1.367
	=	2.82

Rua Bioscience's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.539	+	0.606	+	0.323	+	1.404
	=	2.87

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Rua Bioscience (NZSE:RUA) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Rua Bioscience's Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.539	-	1.454	+	0.75 * 0.606	+	0.5 * 0.323
=	-0.30

Rua Bioscience Total Current Assets Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Rua Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Commerce Place, Awapuni, Gisborne, NZL, 4071

Website

https://www.ruabio.com

Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany and New Zealand.

Rua Bioscience Headlines

No Headlines